Ignyta Announces Acquisition of Actagene Oncology and Entry into Oncology Personalized Medicine

News   May 21, 2013

 
Ignyta Announces Acquisition of Actagene Oncology and Entry into Oncology Personalized Medicine
 
 
 

RELATED ARTICLES

Scientists Develop a Synthetic Solution to Combat Dwindling Supply of Cancer and HIV Drug

News

Supplies of a promising drug for cancer, HIV and possibly other diseases is dwindling, and scientists have struggled to extract more from the marine creatures who produce it. Now, chemists have a synthetic solution.

READ MORE

Neutrons Observe Vitamin B6-dependent Enzyme Activity Useful for Drug Development

News

Scientists performed neutron structural analysis of a vitamin B6-dependent protein, potentially opening avenues for new antibiotics and drugs to battle diseases such as drug-resistant tuberculosis, malaria and diabetes.

READ MORE

Quest Diagnostics to Acquire Cleveland HeartLab

News

Cleveland HeartLab to be the base for Quest's first national center of excellence in cardiometabolic disorders, with a focus on services that help patients and physicians nationwide identify hidden risks of heart disease.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE